Login
Toggle sidebar

Lint: composite-haemangioendothelioma

composite-haemangioendothelioma
Strong List Colon Position
error

"T1: low to intermediate signal intensity"

Line 50:1 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> low'

"T2: high signal intensity"

Line 52:1 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> high'

"T2FS/STIR: high signal"

Line 54:1 · When enboldening an intro, the colon should not be bold. '<strong>T2FS/STIR:</strong> high'

"T1 C+ (Gd): avid enhancement"

Line 56:1 · When enboldening an intro, the colon should not be bold. '<strong>T1 C+ (Gd): </strong>avid'
Acronyms
warning

"Immunohistochemistry stains usually express CD31, ERG and FLI1 and can be positive CD34 and D2-40 1."

Line 41:54 · 'ERG' has no definition. Spell it out if it's unfamiliar to the audience.
Emphasis
warning

"Fusions of the PTBP1-MAML2 and EPC1-PCH2 genes have been observed in neuroendocrine composite haemangioendotheliomas 1."

Line 43:19 · Italics should be used only in exceptional circumstances: '<em>PTBP1-MAML2</em>'
Strong
warning

"T1: low to intermediate signal intensity"

Line 50:1 · Generally, don't use bold in text: '<strong>T1:</strong>'

"T2: high signal intensity"

Line 52:1 · Generally, don't use bold in text: '<strong>T2:</strong>'

"T2FS/STIR: high signal"

Line 54:1 · Generally, don't use bold in text: '<strong>T2FS/STIR:</strong>'

"T1 C+ (Gd): avid enhancement"

Line 56:1 · Generally, don't use bold in text: '<strong>T1 C+ (Gd): </strong>'
List Caps
warning

"Dabska tumour"

Line 76:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Kaposiform haemangioendothelioma"

Line 77:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Kaposi sarcoma"

Line 78:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Associations"

Line 15:1 · "Associations" is under the wrong parent heading (found under "Clinical presentation").

"Subtypes"

Line 21:1 · "Subtypes" is not a recognised heading for this article type.

"Signal characteristics"

Line 47:1 · "Signal characteristics" is not a recognised heading for this article type.
Oxford Comma
suggestion

"Immunohistochemistry stains usually express CD31, ERG and FLI1 and can be positive CD34 and D2-40 1."

Line 41:48 · Use the Oxford comma in 'CD31, ERG and FLI1'.

"form, location and size"

Line 61:5 · Use the Oxford comma in 'form, location and size'.

"relationship to bones, tendons and joints"

Line 64:21 · Use the Oxford comma in 'bones, tendons and joints'.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0